Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer-Reference-Cited by-同舟云学术

Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer

Published:2014-02-03 Issue:5 Volume:34 Page:568-577
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Teles Alves I,Hartjes T,McClellan E,Hiltemann S,Böttcher R,Dits N,Temanni M R,Janssen B,van Workum W,van der Spek P,Stubbs A,de Klein A,Eussen B,Trapman J,Jenster G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2013591.pdf

Reference53 articles.

1. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. Cancer J Clin 2012; 62: 10–29.

2. Shen MM, Abate-Shen C . Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 2010; 24: 1967–2000.

3. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun X-W et al. Recurrent fusion of TMPRSS2 and ETS Transcription factor genes in prostate cancer. Science 2005; 310: 644–648.

4. Dong J-T . Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 2001; 20: 173–193.

5. Clegg NJ, Couto SS, Wongvipat J, Hieronymus H, Carver BS, Taylor BS et al. MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors. PLoS One 2011; 6: e17449.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of NDUFAF6 on breast cancer prognosis: linking mitochondrial regulation to immune response and PD-L1 expression;Cancer Cell International;2024-03-08

2. Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer;Cancer Cell International;2023-10-19

3. Analysis of Genetic Biomarkers, Polymorphisms in ADME-Related Genes and their Impact on Pharmacotherapy for Prostate Cancer;2023-08-17

4. A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis;Frontiers in Oncology;2023-01-16

5. Tumor-derived OBP2A promotes prostate cancer castration resistance;Journal of Experimental Medicine;2022-12-22